InnoCare Pharma (HKSE:09969) Change In Inventory : HK$0.0 Mil (TTM As of Sep. 2023)

View and export this data going back to 2020. Start your Free Trial

What is InnoCare Pharma Change In Inventory?

InnoCare Pharma's change in inventory for the quarter that ended in Sep. 2023 was HK$0.0 Mil. It means InnoCare Pharma's inventory stayed the same from Jun. 2023 to Sep. 2023 .

InnoCare Pharma's change in inventory for the fiscal year that ended in Dec. 2022 was HK$-58.2 Mil. It means InnoCare Pharma's inventory increased by HK$58.2 Mil from Dec. 2021 to Dec. 2022 .

InnoCare Pharma's Total Inventories for the quarter that ended in Sep. 2023 was HK$125.4 Mil.

Days Inventory indicates the number of days of goods in sales that a company has in the inventory. InnoCare Pharma's Days Inventory for the quarter that ended in Sep. 2023 was 420.33.

Inventory Turnover measures how fast the company turns over its inventory within a year. InnoCare Pharma's Inventory Turnover for the quarter that ended in Sep. 2023 was 0.22.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. InnoCare Pharma's Inventory-to-Revenue for the quarter that ended in Sep. 2023 was 0.72.

InnoCare Pharma Change In Inventory Historical Data

The historical data trend for InnoCare Pharma's Change In Inventory can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

InnoCare Pharma Change In Inventory Chart

InnoCare Pharma Annual Data

Trend

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Change In Inventory

Get a 7-Day Free Trial

-2.23

-9.85

-58.20

InnoCare Pharma Quarterly Data
	Dec17	Sep18	Dec18	Jun19	Sep19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Sep22	Dec22	Jun23	Sep23	Dec23
Change In Inventory	Get a 7-Day Free Trial											-	-	-	-	-

InnoCare Pharma Change In Inventory Calculation

Change In Inventory is the difference between last period's ending inventory and the current period's ending inventory.

Change In Inventory for the trailing twelve months (TTM) ended in Sep. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was HK$0.0 Mil.

InnoCare Pharma (HKSE:09969) Change In Inventory Explanation

1. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

InnoCare Pharma's Days Inventory for the quarter that ended in is calculated as:

Days Inventory	=	Average Total Inventories	/	Cost of Goods Sold	*	Days in Period
	=	122.5805	/	26.611	*	365 / 4
	=	420.33

2. Inventory Turnover measures how fast the company turns over its inventory within a year.

InnoCare Pharma's Inventory Turnover for the quarter that ended in Sep. 2023 is calculated as

Inventory Turnover	=	Cost of Goods Sold	/	Average Total Inventories
	=	26.611	/	122.5805
	=	0.22

3. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

InnoCare Pharma's Inventory to Revenue for the quarter that ended in Sep. 2023 is calculated as

Inventory-to-Revenue	=	Average Total Inventories	/	Revenue
	=	122.5805	/	171.432
	=	0.72

InnoCare Pharma Change In Inventory Related Terms

Thank you for viewing the detailed overview of InnoCare Pharma's Change In Inventory provided by GuruFocus.com. Please click on the following links to see related term pages.

InnoCare Pharma (HKSE:09969) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » InnoCare Pharma Ltd (HKSE:09969) » Definitions » Change In Inventory

Comparable Companies

Traded in Other Exchanges

33C:Germany 688428:China

Address

No. 8 Life Science Park Road, Building 8, Zhongguancun Life Science Park, Changping District, Beijing, CHN, 102206

Website

https://www.innocarepharma.com

InnoCare Pharma Ltd is a commercial-stage biopharmaceutical company. It discovers, develops, and commercializes drugs for the treatment of cancer and autoimmune diseases. The company's main product pipeline includes orelabrutinib, ibrutinib, zanubrutinib, tafasitamab, ICP-490, ICP-B02, ICP-248, ICP-192, ICP-723, and ICP-189, among others. Its products are mainly used to treat hematological tumors, solid tumors, and autoimmune diseases. The company is also developing products for the treatment of autoimmune diseases caused by abnormal B-cell or T-cell function.

InnoCare Pharma (HKSE:09969) Headlines

No Headlines